Format

Send to

Choose Destination
Eur Respir Rev. 2018 Jun 6;27(148). pii: 180021. doi: 10.1183/16000617.0021-2018. Print 2018 Jun 30.

Acellular human lung scaffolds to model lung disease and tissue regeneration.

Author information

1
Laboratory for Organ Engineering and Regeneration, Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.
2
Harvard Medical School, Boston, MA, USA.
3
Lund University, Dept of Experimental Medical Sciences, Lung Bioengineering and Regeneration, Lund, Sweden darcy.wagner@med.lu.se.
4
Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
5
Stem Cell Centre, Lund University, Lund, Sweden.

Abstract

Recent advances in whole lung bioengineering have opened new doors for studying lung repair and regeneration ex vivo using acellular human derived lung tissue scaffolds. Methods to decellularise whole human lungs, lobes or resected segments from normal and diseased human lungs have been developed using both perfusion and immersion based techniques. Immersion based techniques allow laboratories without access to intact lobes the ability to generate acellular human lung scaffolds. Acellular human lung scaffolds can be further processed into small segments, thin slices or extracellular matrix extracts, to study cell behaviour such as viability, proliferation, migration and differentiation. Recent studies have offered important proof of concept of generating sufficient primary endothelial and lung epithelial cells to recellularise whole lobes that can be maintained for several days ex vivo in a bioreactor to study regeneration. In parallel, acellular human lung scaffolds have been increasingly used for studying cell-extracellular environment interactions. These studies have helped provide new insights into the role of the matrix and the extracellular environment in chronic human lung diseases such as chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Acellular human lung scaffolds are a versatile new tool for studying human lung repair and regeneration ex vivo.

PMID:
29875137
DOI:
10.1183/16000617.0021-2018
[Indexed for MEDLINE]
Free full text

Conflict of interest statement

Conflict of interest: S.E. Gilpin reports a grant from the Francis Family Foundation (a Parker B. Francis Fellowship), during the conduct of the study; in addition, S.E. Gilpin has a patent pending on Human Airway Stem Cells in Lung Epithelial Engineering (number 20170326273). Conflict of interest: D.E. Wagner reports a grant from the Knut and Alice Wallenberg Foundation, during the conduct of the study; in addition, D.E. Wagner has a patent pending on System and Method for Decellularization and Recellularization of Whole Organs (US Provisional Patent Application No. 61/810,966).

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center